Skip to content
InsideEdge
Investors / filer profile

Track record

What happened ~6 months after each disclosed buy

Not enough completed buys to draw the outcome line yet.

1 of 1
buys higher ~6mo later
+100.1%
median outcome
+10.6%
S&P 500 median, same spans

3 buys still inside the ~6-month window — not scored yet.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$3.71M
combined est. value
INCY
INCYTE CORP
$2.46M
20,841 sh
IMNM
Immunome Inc.
$1.06M
43,415 sh
KROS
Keros Therapeutics, Inc.
$193.3K
16,592 sh

Activity

Open-market buy & sell volume

BuySell
0$159K$318K2025 · bought $47K · sold $020252026 · bought $318K · sold $204K2026
Total +$365.2K bought · −$203.8K sold

All filings on record

Every Form 4 transaction we track for this filer

IMNMBuy
2026-06-05 · Immunome Inc.
$19.3K
in progress
IMNMBuy
2026-06-05 · Immunome Inc.
$68.1K
in progress
IMNMBuy
2026-06-05 · Immunome Inc.
$116.9K
in progress
IMNMSell
2026-06-05 · Immunome Inc.
$194.1K
—
IMNMSell
2026-06-05 · Immunome Inc.
$9.7K
—
KROSGrant
2026-06-03 · Keros Therapeutics, Inc.
7,142
—
KROSBuy
2026-05-15 · Keros Therapeutics, Inc.
$10.6K
in progress
IMNMBuy
2026-05-15 · Immunome Inc.
$103.5K
in progress
INCYGrant
2025-06-10 · INCYTE CORP
2,518
—
KROSGrant
2025-06-04 · Keros Therapeutics, Inc.
5,250
—
IMNMBuy
2025-06-03 · Immunome Inc.
$46.9K
+100.1%

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.